Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor

Detalles Bibliográficos
Autores principales: Hu, Zexi, Hu, Yong, Liu, Xicheng, Xi, Rongwen, Zhang, Aiqun, Liu, Deruo, Xie, Qiang, Chen, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219658/
https://www.ncbi.nlm.nih.gov/pubmed/30443295
http://dx.doi.org/10.18632/oncotarget.26252
_version_ 1783368692517568512
author Hu, Zexi
Hu, Yong
Liu, Xicheng
Xi, Rongwen
Zhang, Aiqun
Liu, Deruo
Xie, Qiang
Chen, Liang
author_facet Hu, Zexi
Hu, Yong
Liu, Xicheng
Xi, Rongwen
Zhang, Aiqun
Liu, Deruo
Xie, Qiang
Chen, Liang
author_sort Hu, Zexi
collection PubMed
description
format Online
Article
Text
id pubmed-6219658
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-62196582018-11-15 Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor Hu, Zexi Hu, Yong Liu, Xicheng Xi, Rongwen Zhang, Aiqun Liu, Deruo Xie, Qiang Chen, Liang Oncotarget Correction Impact Journals LLC 2018-10-16 /pmc/articles/PMC6219658/ /pubmed/30443295 http://dx.doi.org/10.18632/oncotarget.26252 Text en Copyright: © 2018 Hu et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Hu, Zexi
Hu, Yong
Liu, Xicheng
Xi, Rongwen
Zhang, Aiqun
Liu, Deruo
Xie, Qiang
Chen, Liang
Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor
title Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor
title_full Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor
title_fullStr Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor
title_full_unstemmed Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor
title_short Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor
title_sort correction: tumor driven by gain-of-function her2 h878y mutant is highly sensitive to her2 inhibitor
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219658/
https://www.ncbi.nlm.nih.gov/pubmed/30443295
http://dx.doi.org/10.18632/oncotarget.26252
work_keys_str_mv AT huzexi correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor
AT huyong correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor
AT liuxicheng correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor
AT xirongwen correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor
AT zhangaiqun correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor
AT liuderuo correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor
AT xieqiang correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor
AT chenliang correctiontumordrivenbygainoffunctionher2h878ymutantishighlysensitivetoher2inhibitor

Ejemplares similares